Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatr Blood Cancer ; 71(4): e30882, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38267822

RESUMO

NK-1 receptor antagonists (NK1-RA) are key agents for chemotherapy-induced nausea and vomiting (CINV) prevention in patients receiving highly emetogenic chemotherapy. Current pediatric practice guidelines recommend the use of intravenous fosaprepitant or oral aprepitant. However, there are reports of hypersensitivity reactions with fosaprepitant due to polysorbate 80. Intravenous aprepitant does not contain polysorbate 80, but its use in pediatric patients has not been described. In this retrospective, single-center study, 106 pediatric patients received either fosaprepitant or intravenous aprepitant as part of their antiemetic regimen. Intravenous aprepitant was well tolerated and did not lead to any instances of hypersensitivity reactions requiring discontinuation.


Assuntos
Antieméticos , Antineoplásicos , Hipersensibilidade , Morfolinas , Neoplasias , Humanos , Criança , Aprepitanto/uso terapêutico , Estudos Retrospectivos , Polissorbatos/efeitos adversos , Antineoplásicos/efeitos adversos , Antieméticos/efeitos adversos , Vômito/induzido quimicamente , Vômito/prevenção & controle , Vômito/tratamento farmacológico , Neoplasias/complicações , Neoplasias/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...